The Metrix blog
Why your FRM is still a trouble‑shooter, not a strategic partner, and what training has to do with it
Field Reimbursement Managers (FRMs) were never meant to be trouble-shooters. The role was created to shape access…
Metrix's top picks
Five things LTEN 2026 confirmed about the direction of L&D in life sciences
LTEN 2026 surfaced something worth paying attention: the L&D conversation in life sciences has shifted. The questions on the floor were sharper, the challenges more complex, and the appetite for real strategic thinking is more visible than it has been in years. These are the five ideas that stayed with us after the sessions ended….
Early launch training wins: How to spot success and gaps before the 90-day mark
By the time the first 90 days of launch are…
The right-sized launch: How to prioritize training investment when budget is constrained
There is a version of this conversation that happens in…
One team, one message: Building cross-functional collaboration into your product launch
Somewhere in a group practice right now, a rep is…
Stay ahead of the game with regular updates
All results
Why your FRM is still a trouble‑shooter, not a strategic partner, and what training has to do with it
Field Reimbursement Managers (FRMs) were never meant to be trouble-shooters. The role was created to shape access…
Five things LTEN 2026 confirmed about the direction of L&D in life sciences
LTEN 2026 surfaced something worth paying attention: the L&D conversation in life sciences has shifted. The questions…
Early launch training wins: How to spot success and gaps before the 90-day mark
By the time the first 90 days of launch are underway, most pharma launch teams already have…
The right-sized launch: How to prioritize training investment when budget is constrained
There is a version of this conversation that happens in almost every pre-commercial biotech. A VP of…
One team, one message: Building cross-functional collaboration into your product launch
Somewhere in a group practice right now, a rep is calling on a specialist. Two days later,…
The pharma post-launch training gap: Why field performance drops after the honeymoon phase
The national launch meeting is over. The field team has completed their training. They know the product,…
The reimbursement landscape just changed. Does your FRM team know what to tell their accounts?
Access is a critical driver of both launch success and long-term growth. When reimbursement rules shift, the…
Building field access capability from the ground up: Lessons from a launch-ready team
Field access has quietly become one of the most important levers in a successful launch. Yet in…
What keeps NSM strategy alive once the field is back to work?
The ballroom is full. The strategy is clear. The energy is high. National Sales Meetings do exactly…
Why AI makes us more human in training
In life sciences, the most impactful learning experiences don’t just transfer knowledge; they create confidence, empathy, and…
Agility in action: How pharma teams can thrive through disruption
Change isn’t coming to pharma, it’s already here. Product lifecycles are shorter. Access challenges are steeper. Market disruptions, mergers and acquisitions,…
Why pharma training needs a new playbook for rare disease
The rare disease sector is no longer a niche. Nearly half of all new drug approvals in the U.S….